When the Scoreboard Vanished

In a crowded train car or a grocery checkout line, nobody is glancing sideways at a cough anymore, and the daily charts that once defined waking life have simply vanished. A listener writes in with a question that touches how we navigate every shared room: Is COVID-19 still a thing six years later, or is it truly over, and did reporters simply move on because it stopped being news?

To understand how that happened, you have to remember where we started. In January 2020, during the first known month of the outbreak, Time recorded 41,000 English-language articles containing the term "coronavirus". Six years later, news coverage has fallen away even as the virus continued spreading, while countries scaled back routine testing and stopped national case counts. The biological reality and public perception quietly parted ways.

Biologically, SARS-CoV-2 is not gone. It circulates worldwide as an endemic respiratory virus, continually present with recurring waves, where all major circulating lineages descend from Omicron JN.1. Confirmed global cases have climbed to nearly 780 million as of September 2026. In August 2026 alone, across just 58 reporting nations, the World Health Organization logged over 62,000 new cases, warning that every new infection carries risks.

Yet institutional channels also went dark. An analysis found that after the administration took office in January 2025, many CDC public communication platforms had gone silent. Kevin Griffis, who served as the agency's communications director until that March, warned that public health depends on experts communicating in real time. We are left looking at the quiet dashboard. If the virus is still circulating worldwide, where did the catastrophic numbers go, and why did our daily tally suddenly vanish?

The sheer scale of catastrophe has undeniably broken. During 2020 and 2021, COVID-19 stood as the third leading cause of death in the United States, but hospitalization and death rates declined substantially after March 2022 as vaccine and infection immunity accumulated, treatments improved, and variants shifted. Even as the emergency era waned in early April 2023, weekly reported deaths in the country still hovered around 1,000.

By 2026, those numbers look entirely different, though the toll has never reached zero. Over a four-week stretch in August 2026, the World Health Organization logged nearly 1,500 new hospitalizations across reporting countries—noting preliminary counts can capture incidental infections alongside acute illness—and recorded 279 deaths.

Cumulative confirmed tallies show the broader historical weight, surpassing 7.1 million deaths worldwide, with confirmed American deaths exceeding 1.23 million as of September 2026.

Which brings us to the quiet dashboard. What truly disappeared from daily life was not the virus, but the machinery that measured it. On May 11, 2023, after thirteen renewals, the federal public health emergency expired. That legal sunset ended mandatory aggregate case reporting and negative laboratory counts. In their place, officials leaned on sentinel hospitals and municipal wastewater monitoring—a tool the CDC notes can track infections earlier than clinic visits without relying on whether sick individuals have healthcare access or seek tests.

Yet behind those quieter systems, acute danger remains narrowly focused on the fragile. In July 2026, 78 percent of reported global deaths with age data were among adults aged 65 and older. At the same time, the CDC reported that effective antiviral treatments remain significantly underused.

Because emergency mandates ended and everyday life resumed, it is easy to assume the virus has become just like the flu. So the official crisis apparatus was folded into regular respiratory monitoring, but does that mean COVID-19 is now just another seasonal flu?

That idea—that COVID is now just like the flu—is exactly what researchers set out to test. When investigators examined a cohort of Veterans Affairs patients across recent seasons, the two viruses—along with respiratory syncytial virus, or RSV—tracked surprisingly close on hospital admissions, with COVID-19 associated with more severe disease outcomes during the 2022 to 2023 season before differences became less pronounced the following year.

Yet when you look at who survives those infections, the story shifts. Across that same Veterans Affairs group, the 30-day risk of death from COVID-19 consistently outpaced the 0.7 percent seen with both flu and RSV. Tracking patients out to 180 days, the COVID-19 death rate climbed to around 3 percent across both seasons. That lingering severity is why advocates and the World Health Organization argue COVID-19 cannot simply be lumped in with other seasonal bugs. The WHO stresses that the virus is still circulating widely, warning that every reinfection carries health risks and recommending ventilation improvements, masking in high-risk settings, and sustained public surveillance.

Proponents of routine management, however, point to that same study to highlight a very different lesson: the transformative power of immunity. Study authors noted that among groups vaccinated for their respective infections during the 2022 to 2023 season, no difference in 30-day hospitalization risk was found between COVID-19 and influenza. Even more striking, the researchers observed, "No mortality differences between COVID-19 and influenza were found among vaccinated subgroups at any time point through 180 days during either season." To supporters of routine surveillance, that parity showed the emergency phase had passed. Following the expiration of the public health emergency, the Centers for Disease Control and Prevention folded COVID-19 tracking into routine, integrated surveillance alongside flu and other respiratory threats.

The clinical profiles also diverge in other ways. In a CDC study of hospitalized adults aged 60 and older, RSV proved less common than COVID-19 or flu, but patients hospitalized with it faced more severe disease and higher odds of needing intensive oxygen support. At the same time, while flu and RSV admissions drop substantially outside winter peaks, COVID-19 admissions showed less seasonal variation, producing hospitalizations year-round. Even if vaccines level the playing field against acute death, surviving the initial infection doesn't always mean walking away clean.

Surviving the acute infection is only half the story. The Centers for Disease Control and Prevention defines Long COVID as a chronic condition occurring after SARS-CoV-2 infection that persists for at least three months. The National Academies describe it as an infection-associated illness that can progress, remit, or relapse across multiple organ systems. Medical bodies moved early to track it, with the World Health Organization introducing emergency diagnostic codes for post-COVID condition in September 2020.

While worldwide estimates vary, experts broadly concur on a conservative prevalence figure of 2 to 7 percent. In the United States, federal survey data showed that about 7 percent of adults were actively living with Long COVID in early 2024.

The scale of that impairment reaches well beyond lingering fatigue. Over 200 different symptoms have been reported across organ systems. To gauge that impact, federal surveys added specific questions in September 2022, finding that a quarter of adults with active symptoms reported significant limitations to their everyday activities.

That personal toll translates directly into systemic strain. In the United Kingdom, a matched cohort study found patients averaged 30 healthcare visits in their first year post-diagnosis, compared with 16 in comparators. In the United States, economic analyses estimated the condition kept up to four million working-age people out of the labor force, draining up to 230 billion dollars in annual lost earnings.

For those sidelined, help is difficult to reach. Dr. David Kaufman, a physician treating post-viral illness, warned that "the post-pandemic crisis cannot be addressed without thousands more physicians encouraged, trained, and supported to treat patients with these chronic complex diseases." Instead, patients frequently navigate an uncoordinated medical maze while facing steep bureaucratic hurdles trying to document long-term disability for Social Security benefits.

Underlying this impasse is an absence of medical tools: no drug or non-drug therapy has yet been proven definitively effective in large-scale clinical trials. Microbiologist Dr. Amy Proal stressed that "we need to understand the root cause drivers of long Covid to design the clinical trials with the most appropriately targeted therapeutics, and combinations of therapeutics, to help these patients." Until those mechanisms are solved, care remains strictly supportive. With millions living with post-viral disability and hundreds still dying monthly, why did the world stop talking about it?

The quiet began in our own heads. After years of constant alerts, audiences ran into pure cognitive exhaustion and risk fatigue—a documented weariness where repeated warnings provoke diminishing emotional responsiveness as information overload sets in.

Newsrooms followed that retreat. In the classic rhythm of crisis communication, the flood of novel discoveries gave way to long plateaus of familiar data, and editors working with finite space shifted their attention toward competing headlines.

Then the institutional pipeline broke, unraveling the exact mechanism Kevin Griffis warned about: that public health cannot protect anyone without experts communicating in real time. In early 2025, the Department of Health and Human Services began requiring approval for CDC social media posts, and by April nearly every worker at the agency whose primary job was press communication had been laid off. Former communications director Kevin Griffis warned that silencing apolitical guidance undermined agency credibility, while epidemiologist Dr. Jodie Guest noted that expert recommendations were shut down just when the public needed clear, scientifically sound advice.

So to the listener who asked whether COVID-19 is truly over, or just not interesting enough to report: biologically, it is not over. It circulates widely as an ongoing public health challenge, killing hundreds of people every month—predominantly older adults—and leaving millions chronically impaired, with confirmed American deaths surpassing 1.23 million by September 2026. The emergency dashboards are gone, public health messaging was curtailed, and society chose to look elsewhere, but the biological pathogen never packed up and left.